Objectives: The secreted form of ADAM12 is a metalloprotease that may be involved in
placental and fetal growth. We examined whether the concentration of ADAM12 in first-trimester …

Background: Placental protein-13 (PP13) is involved in placental invasion and has been
suggested as a maternal serum marker of preeclampsia (PE) development. However, the …

Background Prophylaxis with low‐dose aspirin may reduce the risk of pre‐eclampsia (PE) if
introduced in first trimester. The performance of first trimester maternal serum screening for …

Objective: To examine whether resistin levels in first trimester maternal serum are associated
with insulin resistance or preeclampsia (PE). Methods: A case-control study of maternal …

The serum adiponectin/leptin ratio (A/L ratio) is a surrogate marker of insulin sensitivity. Pre-eclampsia
(PE) is associated with maternal metabolic syndrome and occasionally impaired …

Objective To determine whether mitochondrial haplogroups function as disease-modifiers or
as susceptibility factors in preeclampsia using a traditional haplogroup association model. …

Numerous circulating microRNAs (miRNAs) have been detected in maternal blood. Initial
studies in third trimester demonstrated differential miRNA expression profiles between …

Objectives Pre-eclampsia (PE) is an important cause of perinatal morbidity and mortality.
Despite an elusive pathophysiology, PE has been associated with changes in maternal serum …

The serum adiponectin-leptin ratio (A/L ratio) is a surrogate marker of insulin sensitivity. Pre-eclampsia
(PE) is associated with maternal metabolic syndrome and occasionally impaired …

… Sophie Calle's first one-person exhibition in North America took place in 1990 at the
Institute for Contemporary Art in Boston, and was followed by a succession of New York gallery …